Genmab A GMAB
NASDAQ GMAB
$54.07 -1.73 (-3.10%)
At close: Nov 10, 2026 · 4:00 PM EST

Genmab A (GMAB) Other financing activities (as filed) (2023 - 2026)

Updated

Genmab A (GMAB) reported Other financing activities (as filed) of -$5 million for the quarter ended Jun 30, 2026.

Analysis

Genmab A (GMAB) Other financing activities (as filed) (2023 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Genmab A's Other financing activities (as filed) came in at -$16 million; for the year ended Dec 31, 2025, it was -$13 million.

  • By year, Other financing activities (as filed) came in at -$9 million in the year ended Dec 31, 2024 and -$14 million in the year ended Dec 31, 2023.
  • The figure for the quarter ended Jun 30, 2026 ranks as the highest quarterly Other financing activities (as filed) since the quarter ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Genmab A 3.52 Bn -5.55 Bn 1.07 Bn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.00 Mn
Jun 30, 2026 -5.00 Mn
Mar 31, 2026 -6.00 Mn
Mar 31, 2025 -2.00 Mn
Mar 31, 2024 -3.00 Mn
Dec 31, 2023 52.00 Mn
Mar 31, 2023 -21.00 Mn
API Access

Genmab A Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=GMAB&period=max&api_key=YOUR_API_KEY